Clinical Characteristics and Outcomes of Invasive Pulmonary Aspergillosis in Patients with Influenza Compared to COVID-19: A Retrospective Cohort Analysis

• by Renwen Zhang, Jun Liu, Ran Li, Li Gu

• April 24, 2026

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

• by Jennifer Kates, William Crown, Collins Gaba, Monica Jordan, Allyala Nandakumar

• May 20, 2026

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

• by Kathryn Wighton

• May 27, 2026

• 6 min

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

• by Kathryn Wighton

• May 12, 2026

• 2 min